New York [US], June 2 (ANI): According to a preclinical study conducted by researchers at Weill Cornell Medicine, genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for relapse of acute myeloid leukaemia (AML), a type of blood cancer,
New York [US], January 21 (ANI): A new study has found that to stop acute myeloid leukaemia, one of the deadliest blood cancers, targeting neighbouring bone cells may be a better strategy.